AtaiBeckley
7 known investors
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions. The company was founded in 2025 through a strategic combination of atai Life Sciences and Beckley Psytech.
BiotechDeep TechDigital HealthMedical DevicesMental Health
Founders & leadership
SR
Srinivas RaoCo-Founder and Chief Executive Officer
CA
Christian AngermayerFounder and Chairman of the Board
Investors · 7
In the news
- AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lillyfinance.yahoo.com · 2026
- Cathie Wood’s ARK sells ATAI stock, buys X-Energy shares By Investing.cominvesting.com · 2026
- AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly - Insider Monkeyinsidermonkey.com · 2026
- AtaiBeckley investor backs Eli Lilly merger | ATAI SEC Filing - Form SCHEDULE 13D/Astocktitan.net · 2026
- ATAI Stock Soars As Eli Lilly Takeover Talks Heat Uptimothysykes.com · 2026
- Is AtaiBeckley (NasdaqGM:ATAI) Overvalued After FDA Support For BPL 003? - Simply Wall St Newssimplywall.st · 2026